In line with previous findings showing the anti-cancer potency of MR against gastric cancer, colorectal cancer, and soft-tissue sarcoma [23–25], low methionine markedly hindered ESCC cell growth in vitro and in vivo (Fig. 2D–J and Supplementary Fig. S3C). This evidence concerns the gene NR3C2 and colorectal cancer.